K17 is a type of intermediate filament protein that is normally expressed during embryogenesis, induced in response to tissue injury, silenced in mature somatic tissues except in certain stem cell populations [6,7], and re-expressed in some cancers [8,9]. This evidence concerns the gene KRT17 and cancer.